Navigation Links
3rd international conference on innovative approaches in head and neck oncology

The European Society for Therapeutic Radiology and Oncology (ESTRO), the European Head and Neck Society (EHNS), and the European Society for Medical Oncology (ESMO) in collaboration with other European partners, have the pleasure of inviting you to report on the 3rd International Conference on innovative approaches In Head and Neck Oncology.

With major emphasis on multidisciplinarity and innovation, this meeting will specifically cover the main following topics:

  • Biological patient profiling and risk factors
  • Emerging diagnostic and therapeutic tools
  • Functional outcome of treatments
  • Global care of patients (cultural issues, psychosocial support, what do patients expect, etc)
  • Clinical controversies based on case discussions such as Evidence-based medicine or practice based medicine, etc

More information on the conference:

More information on Head & Neck cancers on the Radiotherapy Information Centre:

Tremendous achievements in Head & Neck cancers

Head and neck cancers together make up 5% of all cancers diagnosed each year 120,000(1) across Europe. The most common head and neck cancers are:

  • the mouth and tongue (oral cavity)
  • the back of the throat (pharynx)
  • the voice box (larynx)
  • the sinuses

Oral cancers represent 3% of new cases in the UK and 6% in France; while in Sri Lanka, India, Pakistan and Bangladesh, oral cancer is the most common cancer in men and may account for up to 30% of all new cases of cancer (2).

But over the last decade, tremendous achievements have been made in the management of patients with Head & Neck Cancer. Advancements in the understanding of the pathogenesis of Head & Neck malignancies could rapidly lead to the elaboration of tailored treatments:

  • Functional imaging has emerged as a complementary modality to anatomic imaging methods for better staging,
  • Treatment response evaluation and optimal treatment targeting are evolving,
  • Surgery has improved markedly, in particular with better reconstruction techniques moving the limit of operability further.
  • Randomised studies have demonstrated the increasing role of combined modality approaches with chemotherapy and biological targeted therapies.
  • New radiation techniques, expected to impact on survival and quality of life of Head & Neck patients, have taken off the ground

And this is just the beginning, with many more challenges ahead of us.

(1,2) Source: European Society for Therapeutic Radiology and Oncology (ESTRO) 2008,

Media registration

You can pre-register now by writing to On-site registration is possible at the Press Registration Desk. You will be asked for your press card and a letter of assignment.


Contact: Cecile Hardon-Villard
European Society for Medical Oncology

Related medicine news :

1. Lung societies unveil new international classification of lung adenocarcinoma
2. American Chemical Society unveils International Year of Chemistry virtual journal
3. International community called upon to stop the runaway train of cancer in Africa
4. Biodesign hosts international consortium on screening for lung cancer
5. Pier Paolo Pandolfi, M.D., Ph.D., to receive Pezcoller-AACR International Award for Cancer Research
6. International research team reports major findings in prevention and treatment of blood clots
7. International consortium to examine the impact of medical devices on health and retirement
8. New international conference in bionic engineering
9. International clinical trial tests targeted drug for melanoma
10. Experts present new testing methods at international meeting in New Orleans, Nov. 14-18
11. Half of those travelling internationally not aware of potential health risks
Post Your Comments:
(Date:11/24/2015)... ... 24, 2015 , ... With Thanksgiving right around the corner, holiday travel season ... protect your family and vehicle. , According to the National Highway Traffic Safety Administration, ... is sharing the following safety tips from the NHTSA: , ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... it has been designated an Aetna Institute of Quality® Bariatric Surgery Facility for ... the quality and cost of health care services available to its members to ...
(Date:11/24/2015)... M.D. (PRWEB) , ... November 24, 2015 , ... ... new award for its exceptional customer service: the TrustDale certification. The award recognizes ... The Baltimore stone honing , tile and grout, and hard surface restoration ...
(Date:11/24/2015)... ... , ... Autism Speaks, the world’s leading autism science and advocacy organization, will ... generosity of people around the world. On December 1, supporters can make an online ... share the personal stories behind those gifts. , Just as Black Friday and ...
(Date:11/24/2015)... ... ... All her life, Don Peck’s mother wondered if she was a descendant of Samuel Fuller, ... After a 25-year search for information, Don and his aunt discovered that she was not, ... Turns out, it was Don’s father who was descended from not one, but four passengers ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York.  The public is welcome to ... the Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  ... December 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
(Date:11/24/2015)... and VANCOUVER, Nov. 24, 2015 /PRNewswire/ - ESSA ... EPIX ) announced today that the first patient ... of EPI-506 as a treatment for metastatic castration-resistant prostate ... and Canada.  --> the ... In the Phase 1/2 clinical trial, ESSA intends ...
(Date:11/24/2015)... COMMACK, New York , 24. November ... Hersteller des Avery Breathing Pacemaker Systems, ist ... Ph.D., als Clinical Consultant bekannt geben zu ... -->   --> ... Stockholm (Schweden). Von 1984-1986 ...
Breaking Medicine Technology: